Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03338790 |
|---|---|
| Brief Title: | An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CheckMate 9KD) |
| First Submitted : | November 8, 2017 |
| First Submitted that Met QC Criteria : | November 8, 2017 |
| First Posted : | November 9, 2017 |
| Last Update Submitted that Met QC Criteria : | September 9, 2020 |
| Last Update Posted : | September 10, 2020 |